Evidence mapPaperPMID 34957513Full record

SynthesisNutrition reviews2022

Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Trine L Wilkens, Kaare Tranæs, Jane N Eriksen, Lars O Dragsted

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Nutrition reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Trine L WilkensDepartment of Nutrition, Exercise and Sports, Section for Preventive and Clinical Nutrition, University of Copenhagen, Denmark.ORCID 0000-0001-9347-7120
Kaare TranæsDepartment of Nutrition, Exercise and Sports, Section for Preventive and Clinical Nutrition, University of Copenhagen, Denmark.
Jane N EriksenDepartment of Nutrition, Exercise and Sports, Section for Preventive and Clinical Nutrition, University of Copenhagen, Denmark.
Lars O DragstedDepartment of Nutrition, Exercise and Sports, Section for Preventive and Clinical Nutrition, University of Copenhagen, Denmark.
University of Copenhagen · DK

Funding

Wake Forest Field CenterU10AA025286 · NIAAA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LAZO ELIZONDO, MARIANA · 2016 to 2017
$11.4M
NIAAA NIH HHS U10 AA025286
6 · The paper itself

Abstract

contextModerate alcohol consumption is associated with decreased risk of cardiovascular disease (CVD) and improvement in cardiovascular risk markers, including lipoproteins and lipoprotein subfractions.

objectiveTo systematically review the relationship between moderate alcohol intake, lipoprotein subfractions, and related mechanisms. DATA SOURCES: Following PRISMA, all human and ex vivo studies with an alcohol intake up to 60 g/d were included from 8 databases. DATA EXTRACTION: A total of 17 478 studies were screened, and data were extracted from 37 intervention and 77 observational studies.

resultsAlcohol intake was positively associated with all HDL subfractions. A few studies found lower levels of small LDLs, increased average LDL particle size, and nonlinear relationships to apolipoprotein B-containing lipoproteins. Cholesterol efflux capacity and paraoxonase activity were consistently increased. Several studies had unclear or high risk of bias, and heterogeneous laboratory methods restricted comparability between studies.

conclusionsUp to 60 g/d alcohol can cause changes in lipoprotein subfractions and related mechanisms that could influence cardiovascular health. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration no. 98955.

Indexed as

Cardiovascular DiseasesLipoproteinsAlcohol DrinkingApolipoproteins BCholesterol, HDLHumansLipoproteins, LDLApolipoproteins BCholesterol, HDLLipoproteinsLipoproteins, LDLapoB-containing lipoproteinscardiovascular diseasecholesterol efflux capacityhigh-density lipoprotein cholesterolparaoxonase

Identifiers

PMID34957513
PMCPMC9308455
OpenAlexW4226027841

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.